Richard Harlow Cohort Four participant

Richard Harlow

Bucks New University

Richard Harlow

Safer Cap

Designed as a response to an age UK article on the difficulties of living with arthritis, the Safer Cap is a low friction child resistant cap that removes the need to push squeeze or twist to open the bottle

Current child resistant caps work on the principal that an adult level of strength must be used to press, squeeze or twist the cap to release its container. Intended to keep a child from opening the bottle, these cap designs often prevent those suffering from arthritis accessing medication, cleaning products and personal care products. In addition, these caps have proved to be ineffective at keeping children out, with more than 15 children under 5 being taken to hospital for accidental poisoning each day.

Designed as a response to an age UK article on the difficulties of living with arthritis, the SaferCap is a child resistant cap that uses a low friction system to seal the bottle, removing the need to push squeeze or twist to open the container. The product also combats the number of children hurt by accidental poisoning each year by using a number of puzzles designed to distract the child stopping them from opening the bottle. These puzzles cause the child to cycle through the limited solutions, leading them to become bored, or encouraging them to take the container to an adult for help.

Due to physical limitations the elderly population regularly leave harmful substances in easy to access locations. These containers caps are often disabled to make them easier to open, reducing joint pain, but making them easier for a child to access and open. The SaferCap aims to provide a pain free solution for those suffering from joint and muscle conditions, while securing containers contents preventing the needless suffering of young children.

Diagnostics Accelerator Programme: market access planning and evidence generation

Delivered in partnership with the National Institute of Health Research London In Vitro Diagnostics unit this six-week evidence generation focused programme will support medtech innovators to de-risk the path to successful deployment through the development of a business case validating their clinical, financial and social claims. This way, when innovators approach the health system, they are comfortable in the knowledge that the product achieves what it is designed to do.

Applications Closed